NEW YORK, July 26- Invitrogen announced a significant increase in second quarter revenues relative to the year ago period, largely due to the contribution of its newly acquired company, Life Technologies, the company announced on Thursday.

Invitrogen also posted a net loss of $35.1 million, or 67 cents per share, during this latest financial period, compared to a net income of $4.8 million in the second quarter, 2000.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.